Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:525-530

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Kawamura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Kawamura, K.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 1999;34:525-530.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Alternative Angiotensin II Formation in Rat Arteries Occurs Only at Very High Concentrations of Angiotensin I

Kiyo Inoue; Hikaru Nishimura; Jiro Kubota; Keishiro Kawamura

From the Third Department of Internal Medicine, Osaka Medical College, Takatsuki City, Osaka, Japan.

Correspondence to Hikaru Nishimura, MD, Third Department of Internal Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan. E-mail in3023{at}poh.osaka-med.ac.jp

Abstract—Contrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 µmol/L) inhibited the contractions to angiotensin (Ang) I (10-9 to 10-5 mol/L) except at high concentrations of Ang I (>10-7 mol/L). Addition of chymostatin (100 µmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro11,D-Ala12]Ang I (10-8 to 10-5 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 µmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 µg/kg) and [Pro11,D-Ala12]Ang I (7 to 700 µg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang I–induced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro11,D-Ala12]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro11,D-Ala12]Ang I. These findings suggest that biochemical and [Pro11,D-Ala12]Ang I–derived results may not reflect the functional significance of chymase.


Key Words: angiotensin-converting enzyme • chymase • aorta • carotid arteries • hamster




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. L. Diaz-Sylvester, M. C. Fiori, S. M. Dieguez, A. C. Muller, M. L. Lopardo, and C. E. Amorena
Effect of chronic inhibition of converting enzyme on proximal tubule acidification
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2014 - R2020.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs
Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction
Hypertension, November 1, 2007; 50(5): 919 - 925.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. F. Santos, M. A. V. Caprio, E. B. Oliveira, M. C. O. Salgado, D. N. Schippers, D. H. Munzenmaier, and A. S. Greene
Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H775 - H783.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Tom, I. M. Garrelds, E. Scalbert, A. P.A. Stegmann, F. Boomsma, P. R. Saxena, and A.H. J. Danser
ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries: A Matter of Efficiency?
Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 251 - 256.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. McDonald, N. Padmanabhan, M. C. Petrie, C. Hillier, J. M.C. Connell, and J. J.V. McMurray
Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans
Circulation, October 9, 2001; 104(15): 1805 - 1808.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. Inoue, H. Nishimura, J. Kubota, and Y. Kitaura
Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 180 - 183.
[Abstract] [PDF]